Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2017-09-20
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage

Sponsor
Sponsor

  WINDY CITY TIMES

Cook County Health & Hospitals part of study to test new HIV-prevention medication
2016-12-28

facebook twitter google +1 reddit email


Cook County Health & Hospitals System's ( CCHHS ) Ruth M. Rothstein CORE Center is taking part in the first large-scale clinical trial of a long-acting injectable drug for HIV prevention.

The HPTN 083 study will evaluate whether an investigational anti-HIV drug called cabotegravir, which can be taken once every 8 weeks, can safely protect men and transgender women from HIV infection as well as the anti-HIV medication Truvada. Truvada—consisting of two anti-HIV drugs emtricitabine and tenofovir disoproxil fumarate—must be taken once a day to be effective, and it has been shown to reduce the risk of HIV infection in people who are at high risk by up to 92 percent.

Dr. Temitope Oyedele, who is the lead investigator for the study at the CORE Center, said Truvada "has been shown to be effective as pre-exposure prophylaxis against HIV, but the biggest problem is that a lot of people don't remember to take it every day."

"What makes this study so important is it could provide a viable alternative where patients won't have to take a pill every day, but could instead get an injection once every two months and be protected," said Dr. Oyedele, an Attending Physician in the Division of Infectious Diseases at CCHHS' John H. Stroger Jr., Hospital.

HPTN 083 will enroll approximately 4,500 HIV-uninfected men or transgender women who have sex with men at 45 sites in eight countries, including the U.S. and countries in Africa, Asia and South America. Participants must be 18 years or older to participate in the study and be at high risk of getting HIV.

The study will last up to 4.5 years, and participants will be transitioned to locally available HIV prevention services when their participation in the study ends.

The study is sponsored by the National Institutes of Health. ViiV Healthcare and Gilead Sciences ( the manufacturers of cabotegravir and Truvada respectively ) are providing the study medications.

For more information about HPTN 083, visit ClinicalTrials.gov using study identifier NCT02720094.

Contact the CORE Center to learn more about taking part in the trial by calling ( 312 ) 869-4289.


facebook twitter google +1 reddit email




Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

Gay News

Chicago Academy of the Arts' AIDS benefit 2017-09-20 - The Chicago Academy for the Arts will hold its 21st Annual AIDS Benefit at the school, 1010 W. Chicago Ave. The benefit will ...


Gay News

South Side Help Center to mark 30 years, honor leaders, support hurricane recovery 2017-09-20 - Chicago, IL September 20, 2017 —South Side Help Center ( SSHC ), a not-for-profit, community-based organization, will be celebrating 30 years of serving ...


Gay News

Meet AIDS Run & Walk Chicago ambassadors 2017-09-20 - The AIDS Run & Walk Chicago—taking place Sunday, Oct. 1—welcomes people from all walks of life who have been affected by HIV/AIDS. ...


Gay News

TPAN to celebrate '30 Years of Hope' 2017-09-20 - On Sept. 28, Test Positive Awareness Network, or TPAN, will celebrate 30 years of supporting those affected by HIV/AIDS. Merrill Kenna, the organization's ...


Gay News

Midwest LGBTQ Health Symposium registration remains open 2017-09-15 - At Howard Brown Health's 3rd annual Midwest LGBTQ Health Symposium, Oct. 6-7, LGBTQ healthcare providers and advocates will showcase lessons learned and other ...


Gay News

TPAN: Our story is your story 2017-09-15 - A few months ago, Positively Aware's associate editor Enid Vázquez shared some recollections from her 20-plus years of working at TPAN ( TPAN: ...


Gay News

Survey: Diarrhea important but under-reported complaint of HIV/AIDS patients 2017-09-15 - San Francisco, CA — September 12, 2017 — Napo Pharmaceuticals, Inc. ( Napo ), a human health company developing and commercializing novel gastrointestinal ...


Gay News

AIDS Benefit to be hosted by the Chicago Academy for the Arts 2017-09-15 - The students of the Chicago Academy for the Arts will present the 21st annual AIDS Benefit Sept. 22. Each year, Academy students ...


Gay News

South Side Help Center to honor leaders for AIDS, youth, give to hurricane recovery 2017-09-15 - Chicago, IL September 14, 2017 — South Side Help Center ( SSHC ), a not-for-profit, community based organization, will be celebrating 30 years ...


Gay News

Local researchers seek subjects in "smart-PrEP" study 2017-09-13 - Researchers with Cook County Health & Hospitals System ( CCHHS ) are seeking volunteers for a study researching the effectiveness of a "smart-PrEP" ...


 



Copyright © 2017 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor


 



Sponsor

About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group produces Windy City Queercast, & publishes Windy City Times,
The Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community,
Nightspots, Out! Resource Guide, and Identity.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.